Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Current Leases: 2022-2024

Historic Current Leases for Amylyx Pharmaceuticals (AMLX) over the last 3 years, with Dec 2024 value amounting to $1.5 million.

  • Amylyx Pharmaceuticals' Current Leases fell 50.25% to $981,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $981,000, marking a year-over-year decrease of 50.25%. This contributed to the annual value of $1.5 million for FY2024, which is 32.74% down from last year.
  • According to the latest figures from FY2024, Amylyx Pharmaceuticals' Current Leases is $1.5 million, which was down 32.74% from $2.3 million recorded in FY2023.
  • In the past 5 years, Amylyx Pharmaceuticals' Current Leases registered a high of $2.3 million during FY2023, and its lowest value of $1.5 million during FY2024.
  • Over the past 3 years, Amylyx Pharmaceuticals' median Current Leases value was $2.0 million (recorded in 2022), while the average stood at $1.9 million.
  • Its Current Leases has fluctuated over the past 5 years, first grew by 10.64% in 2023, then slumped by 32.74% in 2024.
  • Over the past 3 years, Amylyx Pharmaceuticals' Current Leases (Yearly) stood at $2.0 million in 2022, then increased by 10.64% to $2.3 million in 2023, then tumbled by 32.74% to $1.5 million in 2024.